TNFRSF17 and breast cancer: Consistent with the results in the training set, LBx-BCM detected significantly more methylation in plasma samples from breast cancer than in normal or benign samples as shown in the histogram (Fig. 2A) and box whiskers plots (Fig. 2B; Mann–Whitney test P < 0.0001).